FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Amarin Files sNDA for Vascepa CV Outcomes

Amarin files a supplemental NDA seeking an expanded indication for Vascepa (icosapent ethyl) capsules based on data from the REDUCE-IT cardiovascular ...

Human Drugs

FDA Changing Drug Manufacturing Rules

Bloomberg News says FDA is working on changes to drug manufacturing regulations to reduce problems with contaminated active pharmaceutical ingredients...

Human Drugs

2nd Circuit Strengthens Preemption Law: Attorneys

DLA Piper attorneys say a 2nd Circuit Court of Appeals decision in a case involving Bristol-Myers Squibb and Pfizers Eliquis strengthens preemption la...

Federal Register

Proposed Rule Seeks Improved Mammography Services

Federal Register proposed rule: FDA proposes to update the mammography regulations that were issued under the Mammography Quality Standards Act of 199...

Federal Register

Cell-Tissue Gene Therapy Committee Renewal

Federal Register notice: FDA has announced the renewal of the Cellular, Tissue and Gene Therapies Advisory Committee for an additional two years.

Federal Register

Guide on Pediatric Info in Drug/Biologic Labeling

Federal Register notice: FDA makes available a final guidance entitled Pediatric Information Incorporated Into Human Prescription Drug and Biological ...

Medical Devices

Hidden Device Reports to be Made Available: Gottlieb

FDA Commissioner Scott Gottlieb says that device summary reporting about adverse events that have been hidden to the public and researchers will be ma...

Human Drugs

UCB Inflammatory Arthritis Treatment Approved

FDA approves UCBs Cimiza for treating adults with non-radiographic axial spondyloarthritis, with objective signs of inflammation.

Human Drugs

New York AG Targets Opioid Companies, Sacklers

New York attorney general Letitia James files suit against six opioid manufacturers, the Sackler family, and four opioid distributors over their roles...

Medical Devices

Hitachi Allergy Testing Instrument Cleared

FDA clears a Hitachi Chemical Diagnostics 510(k) for its new high capacity allergy testing instrument, Optigen AP 3600.